• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00570530
Medical Device Problem Code Positioning Problem (3009)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/13/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported to boston scientific corporation that a wallflex biliary covered stent was used to treat a cholangiocarcinoma during an endoscopic retrograde cholangiopancreatography (ercp) with stent placement procedure performed on (b)(6) 2023.The patient's anatomy was tortuous and was dilated prior to stent placement.During the procedure, after the stent deployment, it was noted that the distal portion of the stent was moved to the common bile duct.The stent was then repositioned using forceps and another wallflex biliary stent was used to complete the procedure.There were no patient complications reported as a result of this event.
 
Additional Manufacturer Narrative
Block h6: imdrf device code a1502 captures the reportable event of stent positioning issue.
 
Additional Manufacturer Narrative
Block h6 (conclusion code) has been updated based on the reopened investigation on december 02, 2023.Block h6: imdrf device code a1502 captures the reportable event of stent positioning issue.
 
Event or Problem Description
It was reported to boston scientific corporation that a wallflex biliary covered stent was used to treat a cholangiocarcinoma during an endoscopic retrograde cholangiopancreatography (ercp) with stent placement procedure performed on (b)(6) 2023.The patient's anatomy was tortuous and was dilated prior to stent placement.During the procedure, after the stent deployment, it was noted that the distal portion of the stent was moved to the common bile duct.The stent was then repositioned using forceps and another wallflex biliary stent was used to complete the procedure.There were no patient complications reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX BILIARY
Common Device Name
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18047572
Report Number3005099803-2023-05913
Device Sequence Number7499951
Product Code FGE
UDI-Device Identifier08714729764915
UDI-Public08714729764915
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K140630
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/29/2024
Device Model NumberM00570530
Device Catalogue Number7053
Device Lot Number0030627408
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 10/13/2023
Supplement Date Received by Manufacturer11/02/2023
Initial Report FDA Received Date11/01/2023
Supplement Report FDA Received Date11/20/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured11/30/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-